期刊文献+

CEPO经Mash1信号促进大鼠局部脑缺血后纹状体内神经发生 被引量:1

Carbamylated erythropoietin via Mash1 signaling promotes neurogenesis in the ischemic striatum following focal cerebral ischemia in rats
下载PDF
导出
摘要 为检测氨甲酰化促红细胞生成素(CEPO)在大鼠脑缺血后发生过程中的作用及其相关信号通路,本实验将成年大鼠大脑中动脉栓塞(MCAO)后立即尾静脉给予CEPO(50μg/kg)。结果显示:CEPO可显著降低大鼠MCAO后3d梗塞面积,增加缺血侧神经干细胞增殖、促进神经干细胞分化成为神经元。CEPO的促神经发生效应与缺血侧纹状体内前神经元bHLH转录因子Mash1的表达上调密切相关。本结果提示CEPO对脑缺血具有神经保护作用,Mash1信号在缺血侧纹状体内可能介导CEPO增强的神经发生和神经元分化效应。 To investigate the effect of carbamylated erythropoietin ( CEPO ) on neurogenesis and the associated signaling pathways in a model of cerebral ischemia in rats, rats subjected to middle cerebral artery occlusion (MCAO) were treated immediately with CEPO after MCAO. Cerebral infarct volumes were assessed at 3 days post-MCAO. CEPO at a dose of 50μg/kg significantly reduced infarct volume and increased neural stem cells proliferation and promoted neural stem cells differentiation into neurons in the ischemic striatum, which was associated with up-regulation of Mashl, a pro-neuron basic helix-loop-helix protein transcription factor. Taken together, these actions of CEPO are likely to contribute to their neuroprotection following cerebral ischemia; the Mashl signaling pathway may mediate CEPO-en- hanced neurogenesis and neuronal differentiation in the ischemic striatum.
出处 《神经解剖学杂志》 CAS CSCD 北大核心 2009年第6期641-646,共6页 Chinese Journal of Neuroanatomy
基金 江苏省自然科学基金(BK2002056)资助项目
关键词 脑缺血 神经发生 CEPO Mash1 纹状体 大鼠 cerebral ischemia, neurogenesis, CEPO, Mash1, striatum, rat
  • 相关文献

参考文献11

  • 1Arvidsson A, Collin T, Kirik D et al. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med, 2002 ;8:963 -970.
  • 2Wang L, Zhang Z, Wang Y et al. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke, 2004 ;35 : 1732 - 1737.
  • 3Leist M, Ghezzi P, Grasso G et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science, 2004;305:239 - 242.
  • 4Wang Y, Zhang ZG, Rhodes K et al. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia. Br J Pharmacol, 2007 ; 151 : 1377 - 1384.
  • 5Fiordaliso F, Chimenti S, Staszewsky L et al. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemiareperfusion injury. Proc Natl Acad Sci USA, 2005 ; 102:2046 - 2051.
  • 6Brines M, Cerami A. Emerging biological roles for erytbropoietin in the nervous system. Nat Rev Neurosci, 2005 ;6:484 -494.
  • 7Liu F, You Y, Li X et al. Brain injury does not alter the intrinsic differentiation potential of adult neuroblasts. J Neurosci, 2009;29: 5075 - 5087.
  • 8Iwai M, Cao G, Yin Wet al. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia/ischemia in rats. Stroke, 2007 ;38:2795 -2803.
  • 9Montero M, Poulsen FR, Noraberg J et al. Comparison of neuroprotective effects of erythropoietin ( EPO ) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures. Exp Neurol, 2007 ;204 : 106 - 117.
  • 10Villa P, van Beek J, Larsen AK et al. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J Cereb Blood Flow Metab, 2007 ;27:552 - 563.

同被引文献33

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部